2021
How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer?
Chagpar A, Lannin D, Mougalian S, Berger E, Gross C, Horowitz N, Sanft T, DiGiovanna M, Golshan M, Pusztai L. How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer? Journal Of Clinical Oncology 2021, 39: e18708-e18708. DOI: 10.1200/jco.2021.39.15_suppl.e18708.Peer-Reviewed Original ResearchUse of NTNeoadjuvant therapyEarly pandemic periodBreast cancerNon-metastatic breast cancerPractice settingsEarly pandemicFlatiron Health databaseNeoadjuvant endocrine therapyTechnology-enabled abstractionSame period one yearSimilar clinicopathologic featuresLongitudinal electronic health recordsPeriod one yearElectronic health recordsTNBC subsetEndocrine therapyPatient ageTN patientsClinicopathologic featuresContemporary cohortClinical stageCancer clinicCancer managementHigh risk
2015
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma
Delpech Y, Bashour SI, Lousquy R, Rouzier R, Hess K, Coutant C, Barranger E, Esteva FJ, Ueno NT, Pusztai L, Ibrahim NK. Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma. British Journal Of Cancer 2015, 113: 1003-1009. PMID: 26393887, PMCID: PMC4651124, DOI: 10.1038/bjc.2015.308.Peer-Reviewed Original ResearchConceptsNon-metastatic breast cancerBreast cancerClinical nomogramCox proportional hazards regression modelProportional hazards regression modelsBone-targeted therapiesHormone receptor statusEarly breast cancerLymph node statusLymphovascular space invasionEarly breast carcinomaAnalysis of patientsHazards regression modelsPathologic variablesReceptor statusDistant metastasisTumor characteristicsNode statusSpace invasionT classificationPatient populationMedical recordsBreast carcinomaCommon siteConcordance index
2011
P2-12-06: Nomogram To Predict Subsequent Bone Metastasis in Patients with Non Metastatic Breast Carcinomas.
Lousquy R, Delpech Y, Rouzier R, Gligorov J, Hsu L, Barranger E, Pusztai L, Uzan S, Hortobagyi G, Coutant C, Ibrahim N. P2-12-06: Nomogram To Predict Subsequent Bone Metastasis in Patients with Non Metastatic Breast Carcinomas. Cancer Research 2011, 71: p2-12-06-p2-12-06. DOI: 10.1158/0008-5472.sabcs11-p2-12-06.Peer-Reviewed Original ResearchNon-metastatic breast cancerMetastatic breast cancerBreast cancerBone metastasesConcordance indexHigh riskCox proportional hazards regression modelNon-metastatic breast carcinomaMultivariate logistic regression analysisProportional hazards regression modelsM.D. Anderson Cancer CenterBreast cancer molecular subtypesMethods Medical recordsSubsequent bone metastasesLymph node statusLymphovascular space invasionSelection of patientsTime of diagnosisMetastatic breast carcinomaHazards regression modelsAnderson Cancer CenterCancer molecular subtypesLogistic regression analysisDesign of trialsAdjuvant hormonotherapy